HomeZNTL • NASDAQ
add
Zentalis Pharmaceuticals Inc
Previous close
$3.00
Day range
$2.96 - $3.15
Year range
$2.84 - $18.32
Market cap
223.28M USD
Avg Volume
2.93M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 65.15M | 11.65% |
Net income | -88.28M | 21.55% |
Net profit margin | — | — |
Earnings per share | -1.24 | 32.97% |
EBITDA | -64.82M | -11.75% |
Effective tax rate | -0.30% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 426.38M | -22.89% |
Total assets | 491.68M | -20.88% |
Total liabilities | 109.10M | 11.14% |
Total equity | 382.58M | — |
Shares outstanding | 71.11M | — |
Price to book | 0.56 | — |
Return on assets | -31.05% | — |
Return on capital | -35.00% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -88.28M | 21.55% |
Cash from operations | -35.14M | 55.67% |
Cash from investing | 34.49M | -52.71% |
Cash from financing | 9.00K | -100.00% |
Net change in cash | -640.00K | -100.28% |
Free cash flow | -14.35M | 31.76% |
About
Founded
2014
Website
Employees
124